Luyten G P, Mooy C M, Post J, Jensen O A, Luider T M, de Jong P T
Department of Ophthalmology, Erasmus University Rotterdam, The Netherlands.
Cancer. 1996 Nov 1;78(9):1967-71. doi: 10.1002/(sici)1097-0142(19961101)78:9<1967::aid-cncr18>3.0.co;2-w.
Uveal melanoma often metastasizes late and preferentially to the liver, in contrast to cutaneous melanoma. The objective of the current study was to evaluate the histopathologic and immunohistochemical changes in primary uveal melanomas and their corresponding metastases.
The morphology and immunohistochemical reactivity for the melanoma-associated antibodies HMB-45, S-100 protein, and NKI-C3 were assessed for 29 primary uveal melanomas and their corresponding metastatses.
A significant difference in cell type of the primary and the metastatic uveal melanoma was found (P = 0.0001). The metastases derived from the 29 patient's revealed 82.5% epithelioid or nonclassifiable cells. Positive staining of the primary uvea melanomas and their metastases was found to be 93% and 91%, respectively, for HMB-45, 80% and 66%, respectively, for S-100, and 56% and 71%, respectively, for NKI-C3.
Metastases of uveal melanomas are comprised of a higher grade of malignant cell types. Nonclassifiable cells can be observed in 40% of metastatic lesions. In the current study, HMB-45 proved to be the most sensitive immunohistochemical marker in the analysis of metastatic uveal melanoma and should be used as part of a panel of monoclonal antibodies in the analysis of any metastatic tumor of unknown origin.
与皮肤黑色素瘤不同,葡萄膜黑色素瘤通常发生转移较晚,且优先转移至肝脏。本研究的目的是评估原发性葡萄膜黑色素瘤及其相应转移灶的组织病理学和免疫组化变化。
对29例原发性葡萄膜黑色素瘤及其相应转移灶进行形态学评估,并检测黑色素瘤相关抗体HMB-45、S-100蛋白和NKI-C3的免疫组化反应性。
原发性和转移性葡萄膜黑色素瘤的细胞类型存在显著差异(P = 0.0001)。来自29例患者的转移灶显示82.5%为上皮样或不可分类细胞。原发性葡萄膜黑色素瘤及其转移灶中,HMB-45的阳性染色率分别为93%和91%,S-100分别为80%和66%,NKI-C3分别为56%和71%。
葡萄膜黑色素瘤转移灶由更高等级的恶性细胞类型组成。40%的转移灶中可观察到不可分类细胞。在本研究中,HMB-45被证明是分析转移性葡萄膜黑色素瘤时最敏感的免疫组化标志物,在分析任何来源不明的转移性肿瘤时,应作为一组单克隆抗体的一部分使用。